Crossref
Analysis Asks: Are GLP-1 Drugs Safe in People With Frailty?
JAMA · 30.10.2026
DOI: 10.1001/jama.2026.22482 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, online erschienen am 30.10.2026. Verfasst von Anna Bock. Beteiligte Einrichtung: Freelance Journalist and Physician Assistant Student, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
This Medical News article discusses an analysis of cardiovascular benefits and safety of semaglutide use in trial participants with frailty, defined by accumulated age-related health deficits.
Autor:innen und Institutionen
- Freelance Journalist and Physician Assistant Student, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Zitieren
APA
Bock, A. (2026). Analysis Asks: Are GLP-1 Drugs Safe in People With Frailty?. JAMA. https://doi.org/10.1001/jama.2026.22482
Vancouver
Bock A. Analysis Asks: Are GLP-1 Drugs Safe in People With Frailty?. JAMA. 2026. doi:10.1001/jama.2026.22482
BibTeX
@article{Bock2026,
author = {Bock, Anna},
title = {Analysis Asks: Are GLP-1 Drugs Safe in People With Frailty?},
journal = {JAMA},
year = {2026},
doi = {10.1001/jama.2026.22482}
}
EUVIMED